Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katherine L. Byar"'
Autor:
Katherine L, Byar, Tricia, Fredericks
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:70-76
Leiomyosarcoma (LMS) is the most common soft tissue sarcoma in adults and can occur in any part of the body. Uterine leiomyosarcoma (uLMS) is the most common location for LMS, making up 2% to 5% of all uterine malignancies. It is an aggressive tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b0674db1a0511306204e3b02682e8a
https://doi.org/10.6004/jadpro.2022.13.1.6
https://doi.org/10.6004/jadpro.2022.13.1.6
Autor:
Katherine L Byar, Matthew Lunning
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Katherine L. Byar, MSN, ANP-BC, BMTCN®, and Matthew Lunning, DO, FACP, covered how to tackle challenges in the treatment of aggressive lymphomas by understanding how to apply emerging data, reviewing optimal therapies and treatment recommendations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6acd12ce7fc5e6392dbd559d2b066887
https://doi.org/10.6004/jadpro.2020.11.3.20
https://doi.org/10.6004/jadpro.2020.11.3.20
'The Cancer Basics book series was developed to offer fundamentals of cancer and its treatment to recently graduated and experienced nurses looking for professional growth and knowledge in their oncology specialty. This third edition of Cancer Basics
Autor:
Katherine L. Byar
Publikováno v:
Seminars in Oncology Nursing. 20:20-25
Objectives To present the relevant information for the education of patients with B-cell non-Hodgkin’s lymphoma (NHL) who are about to undergo radioimmunotherapy (RIT) with yttrium 90 ( 90 Y) ibritumomab tiuxetan. Data sources Published clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42dcc3abe72d914ea07d697d5aacecd9
https://doi.org/10.1053/j.soncn.2004.02.010
https://doi.org/10.1053/j.soncn.2004.02.010
Publikováno v:
Oncology nursing forum. 33(1)
PURPOSE/OBJECTIVES: To identify differences in fatigue, other physical symptoms, and psychological symptoms and their relationship to quality of life (QOL) during chemotherapy and as long as one year after. DESIGN: Longitudinal, descriptive design em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c979e86005071074579a6e2bbe76cdeb
https://pubmed.ncbi.nlm.nih.gov/16470230
https://pubmed.ncbi.nlm.nih.gov/16470230
Autor:
Katherine L. Byar, Mary Beth Riley
Publikováno v:
Seminars in oncology nursing. 20(1 Suppl 1)
Objectives To present the rationale for and development of radioimmunotherapy (RIT) for non-Hodgkin's lymphoma (NHL), which culminated in the FDA's approval of yttrium 90 ( 90 Y) ibritumomab tiuxetan in February 2002. Data sources Published clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72b7daee6b3af80a66846702330c5d67
https://pubmed.ncbi.nlm.nih.gov/15160855
https://pubmed.ncbi.nlm.nih.gov/15160855
Publikováno v:
Cancer Nursing. 28:148
This cross-sectional study used a mailed survey to evaluate the quality of life (QOL) of individuals at least 5 years post-autologous stem cell transplant and to determine instrument preference. Instruments selected were the Medical Outcomes Study-Sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee589188cc229b84a4943b70c60e3aee
https://doi.org/10.1097/00002820-200503000-00010
https://doi.org/10.1097/00002820-200503000-00010